SX 3228

Known as: SX-3228 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1998-2010
01219982010

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
SX-3228, 6-benzyl-3-(5-methoxy-1,3,4-oxadiazol-2-yl)-5,6,7,8-tetrahydro-1,6-naphthyridin-2(1H)-one, is a newly-synthesized… (More)
Is this relevant?
2010
2010
SX-3228, 6-benzyl-3-(5-methoxy-1,3,4-oxadiazol-2-yl)-5,6,7,8-tetrahydro-1,6-naphthyridin-2(1H)-one, is a newly synthesized… (More)
Is this relevant?
1999
1999
The experiments in this study compared the pharmacological properties of several BZ-omega receptor ligands, including the… (More)
Is this relevant?
1999
1999
The effects of the benzodiazepine1 (BZ1) receptor agonist SX-3228 were studied in rats (N = 12) implanted for chronic sleep… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
1998
1998
The present experiments compared the anxiolytic-like effects of the benzodiazepine (BZD) hypnotic triazolam with those of four… (More)
Is this relevant?